This page keeps track of new/upcoming treatment options for Familial Adenomatous Polyposis (FAP). What’s in development? What’s promising? What’s available soon? Find out below… Current topics include guselkumab, anti-helminthic drugs, niclosamide, erlotinib, rapamycin, and more.
SubscribeLast updated:
News
Research
Clinical Trials
- A Study of Guselkumab in Participants With Familial Adenomatous Polyposis May 20, 2020
- Encapsulated Rapamycin (eRapa) to Prevent Progression in Familial Adenomatous Polyposis Patients Under Active Surveillance May 12, 2020
- Erlotinib Hydrochloride in Reducing Duodenal Polyp Burden in Patients With Familial Adenomatous Polyposis at Risk of Developing Colon Cancer May 5, 2020
- Niclosamide for Familial Adenomatous Polyposis Mar 5, 2020
- Safety and Efficacy of Eflornithine Combined With Sulindac in Patients With Familial Adenomatous Polyposis (FAP) [Completed] Feb 17, 2020